JMPWA
JAZZ icon

JP Morgan Private Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$781K Sell
6,032
-662
-10% -$88.2K ﹤0.01% 1068
2023
Q2 		$830K Sell
6,694
-5,246
-44% -$706K ﹤0.01% 825
2023
Q1 		$1.75M Sell
11,940
-122
-1% -$18K ﹤0.01% 933
2022
Q4 		$1.92M Buy
12,062
+88
+0.7% +$12.9K ﹤0.01% 869
2022
Q3 		$1.6M Sell
11,974
-183
-2% -$27.8K ﹤0.01% 928
2022
Q2 		$1.9M Buy
12,157
+184
+2% +$28.3K ﹤0.01% 870
2022
Q1 		$1.86M Buy
11,973
+2,106
+21% +$306K ﹤0.01% 931
2021
Q4 		$1.26M Sell
9,867
-13
-0.1% -$1.71K ﹤0.01% 1123
2021
Q3 		$1.29M Buy
9,880
+550
+6% +$83.1K ﹤0.01% 1097
2021
Q2 		$1.66M Buy
9,330
+1,980
+27% +$343K ﹤0.01% 959
2021
Q1 		$1.21M Sell
7,350
-1,344
-15% -$221K ﹤0.01% 958
2020
Q4 		$1.44M Sell
8,694
-1,409
-14% -$210K ﹤0.01% 863
2020
Q3 		$1.44M Buy
10,103
+149
+1% +$18.5K 0.01% 747
2020
Q2 		$1.1M Buy
9,954
+3,742
+60% +$414K 0.01% 774
2020
Q1 		$620K Buy
6,212
+4,148
+201% +$536K ﹤0.01% 852
2019
Q4 		$308K Buy
2,064
+171
+9% +$23.3K ﹤0.01% 1226
2019
Q3 		$243K Sell
1,893
-2,686
-59% -$360K ﹤0.01% 1266
2019
Q2 		$653K Buy
4,579
+746
+19% +$100K ﹤0.01% 891
2019
Q1 		$548K Sell
3,833
-633
-14% -$82.6K ﹤0.01% 992
2018
Q4 		$554K Sell
4,466
-116
-3% -$17.2K ﹤0.01% 926
2018
Q3 		$771K Buy
4,582
+24
+0.5% +$4.13K ﹤0.01% 916
2018
Q2 		$785K Sell
4,558
-59
-1% -$9.64K ﹤0.01% 848
2018
Q1 		$697K Buy
4,617
+144
+3% +$21.1K ﹤0.01% 763
2017
Q4 		$602K Sell
4,473
-194
-4% -$26.9K ﹤0.01% 812
2017
Q3 		$682K Buy
+4,667
New +$706K ﹤0.01% 741
2016
Q3 		– Sell
-1,446
Closed -$204K – 1247
2016
Q2 		$204K Buy
+1,446
New +$213K ﹤0.01% 1145
2015
Q1 		– Sell
-1,848
Closed -$302K – 1157
2014
Q4 		$302K Sell
1,848
-4
-0.2% -$664 ﹤0.01% 873
2014
Q3 		$298K Buy
+1,852
New +$285K ﹤0.01% 847
2014
Q1 		– Sell
-1,631
Closed -$206K – 881
2013
Q4 		$206K Buy
+1,631
New +$169K ﹤0.01% 607

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Private Wealth Advisors's JAZZ Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 9.9% in Q3 2023, selling an estimated $88.2K and leaving 6,032 shares worth $781K. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

JP Morgan Private Wealth Advisors first reported a position in JAZZ in Q4 2013 and has held it in 29 quarters since. The position peaked at $1.92M in Q4 2022. 485 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 6,032 shares of Jazz Pharmaceuticals worth $781K as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 662 Jazz Pharmaceuticals shares in Q3 2023, an estimated $88.2K.
  • Jazz Pharmaceuticals made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1068 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 29 quarters since.
  • JP Morgan Private Wealth Advisors's Jazz Pharmaceuticals position peaked at $1.92M in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.